Crossject is revolutionizing needle free injection


Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has seven solutions in advanced stages of development, six of which are for emergency situations.  

Zeneo illustration


Our news

Image de l'actualité

Biomed Event by Invest Securities

Résumé de l'actualité

January 24, 2023

Image de l'actualité